WO2004016768A3 - Compositions et methodes permettant de deduire des inferences d'ascendance - Google Patents

Compositions et methodes permettant de deduire des inferences d'ascendance Download PDF

Info

Publication number
WO2004016768A3
WO2004016768A3 PCT/US2003/026229 US0326229W WO2004016768A3 WO 2004016768 A3 WO2004016768 A3 WO 2004016768A3 US 0326229 W US0326229 W US 0326229W WO 2004016768 A3 WO2004016768 A3 WO 2004016768A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
ancestry
compositions
trait
aims
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/026229
Other languages
English (en)
Other versions
WO2004016768A2 (fr
Inventor
Tony N Frudakis
Mark D Shriver
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DNAPrint Genomics Inc
Original Assignee
DNAPrint Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DNAPrint Genomics Inc filed Critical DNAPrint Genomics Inc
Priority to CA 2496155 priority Critical patent/CA2496155A1/fr
Priority to JP2005502072A priority patent/JP2006514553A/ja
Priority to AU2003265572A priority patent/AU2003265572A1/en
Priority to EP03788685A priority patent/EP1578944A4/fr
Publication of WO2004016768A2 publication Critical patent/WO2004016768A2/fr
Anticipated expiration legal-status Critical
Publication of WO2004016768A3 publication Critical patent/WO2004016768A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B10/00—ICT specially adapted for evolutionary bioinformatics, e.g. phylogenetic tree construction or analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B45/00—ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Addiction (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Physiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Obesity (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Psychology (AREA)

Abstract

L'invention concerne des polynucléotides de marqueurs d'informations d'ascendance (AIM) qui contiennent un seul polymorphisme nucléotidique ou une insertion ou une suppression, ainsi que des méthodes d'utilisation de panneaux d'AIM permettant de déduire une inférence comme trait d'un individu. Ce trait peut être, for exemple, un ancêtre biogéographique, un trait de pigmentation, une réactivité à un médicament, ou une susceptibilité à une maladie. L'invention concerne également des méthodes permettant de déterminer la proportion d'ascendance d'un individu. L'invention concerne enfin des réactifs et des kits.
PCT/US2003/026229 2002-08-19 2003-08-19 Compositions et methodes permettant de deduire des inferences d'ascendance Ceased WO2004016768A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA 2496155 CA2496155A1 (fr) 2002-08-19 2003-08-19 Compositions et methodes permettant de deduire des inferences d'ascendance
JP2005502072A JP2006514553A (ja) 2002-08-19 2003-08-19 祖先を推論するための組成物および方法
AU2003265572A AU2003265572A1 (en) 2002-08-19 2003-08-19 Compositions and methods for inferring ancestry
EP03788685A EP1578944A4 (fr) 2002-08-19 2003-08-19 Compositions et methodes permettant de deduire des inferences d'ascendance

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40435702P 2002-08-19 2002-08-19
US60/404,357 2002-08-19
US46761303P 2003-05-02 2003-05-02
US60/467,613 2003-05-02

Publications (2)

Publication Number Publication Date
WO2004016768A2 WO2004016768A2 (fr) 2004-02-26
WO2004016768A3 true WO2004016768A3 (fr) 2005-12-22

Family

ID=31891429

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/026229 Ceased WO2004016768A2 (fr) 2002-08-19 2003-08-19 Compositions et methodes permettant de deduire des inferences d'ascendance

Country Status (5)

Country Link
EP (1) EP1578944A4 (fr)
JP (2) JP2006514553A (fr)
AU (2) AU2003265572A1 (fr)
CA (1) CA2496155A1 (fr)
WO (1) WO2004016768A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006089238A2 (fr) * 2005-02-18 2006-08-24 Dna Print Genomics Dosages multiplex pour inferer l'ascendance
FR2914316A1 (fr) * 2006-11-15 2008-10-03 Igna Inst Genetique Nantes Atl Methodes et outils pour determiner l'origine d'un sujet.
FR2910147B1 (fr) * 2006-12-19 2009-02-06 Galderma Res & Dev S N C Snc Methode correctrice de traitement de resultats d'experiences transcriptomiques obtenus par analyse differentielle
US20140067355A1 (en) * 2012-09-06 2014-03-06 Ancestry.Com Dna, Llc Using Haplotypes to Infer Ancestral Origins for Recently Admixed Individuals
US11341378B2 (en) * 2016-02-26 2022-05-24 Nec Corporation Information processing apparatus, suspect information generation method and program
CN111061510B (zh) * 2019-12-12 2021-01-05 湖南毂梁微电子有限公司 一种可扩展的asip结构平台及指令处理方法
US20240301500A1 (en) * 2021-02-24 2024-09-12 Myriad Genetics, Inc. Global polygenic risk assessment for breast cancer
CN116064842B (zh) * 2022-11-17 2025-04-29 南方医科大学 一种用于降解检材推断的生物地理祖先DIPs和性别鉴定的复合扩增盒
CN118028493B (zh) * 2024-04-11 2024-07-23 南方医科大学 包含73个多态性dip位点的复合扩增检测体系及其应用
JP7737771B1 (ja) * 2025-07-17 2025-09-11 一般社団法人全国キャットクラブ 情報提供システム
CN121506242A (zh) * 2025-10-27 2026-02-10 石家庄博瑞迪生物技术有限公司 一种品种特异snp位点筛选方法及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002097047A2 (fr) * 2001-05-25 2002-12-05 Dnaprint Genomics, Inc. Compositions et methodes d'inference des traits de pigmentation
US20030172065A1 (en) * 2001-03-30 2003-09-11 Sorenson James L. System and method for molecular genealogical research

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008899D0 (en) * 2000-04-11 2000-05-31 Isis Innovation DNA analysis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030172065A1 (en) * 2001-03-30 2003-09-11 Sorenson James L. System and method for molecular genealogical research
WO2002097047A2 (fr) * 2001-05-25 2002-12-05 Dnaprint Genomics, Inc. Compositions et methodes d'inference des traits de pigmentation

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
CHAKRABORTY R. ET AL.: "Admixture as a tool for finding linked genes and detecting that difference from allelic association between loci.", PNAS, vol. 85, December 1988 (1988-12-01), pages 9119 - 9123, XP002992781 *
CHAKRABORTY R. ET AL.: "'Unique' alleles in admixed populations: a strategy for determining 'hereditary' population differences of disease frequencies.", ETHNICITY & DISEASE., vol. 1, 1991, pages 245 - 256, XP008056101 *
COLLINS-SCHRAMM H. ET AL.: "Ethnic-difference markers for use in mapping by admixture linkage disequilibrium.", AM. J. HUM. GENET., vol. 70, no. 3, 11 March 2002 (2002-03-11), pages 737 - 750, XP002992780 *
DATABASE GENBANK 20 May 2000 (2000-05-20), HATTORI M. ET AL.: "Homo sapiens 98, 305 genomic DNA of 11q23.", XP002992783 *
DATABASE GENBANK 25 July 1997 (1997-07-25), EVANS G. ET AL., XP002992782 *
DRHAM-PIERRE D. ET AL.: "Estimation of carrier frequenca of a 2.7 kb deletion allele of the p gene associated with OCA2 in African-American.", HUM. MUTATION, vol. 7, 1996, pages 370 - 373, XP008056104 *
FERNANDEZ J. ET AL.: "Association of African genetic admixture with resting metabolic rate and abesity among women.", OBESITY RES., vol. 11, no. 7, 7 July 2003 (2003-07-07), pages 904 - 911, XP002992779 *
MCKEIGUE P. ET AL.: "Estimation of admixture and detection of linkage in admixed populations by a Bayesian approach:application to African-American polulations.", ANN. HUM. GENET., vol. 64, no. 2, 2000, pages 171 - 186, XP008056102 *
PARRA E. ET AL.: "Estimating African Americab admixture proportions by use of population-specific alleles.", AM. J. HUM. GENET., vol. 63, 1998, pages 1839 - 1851, XP002310801 *

Also Published As

Publication number Publication date
JP2012050432A (ja) 2012-03-15
EP1578944A4 (fr) 2009-12-23
AU2003265572A1 (en) 2004-03-03
CA2496155A1 (fr) 2004-02-26
AU2009225275A1 (en) 2009-10-29
WO2004016768A2 (fr) 2004-02-26
EP1578944A2 (fr) 2005-09-28
JP2006514553A (ja) 2006-05-11

Similar Documents

Publication Publication Date Title
WO2004023092A3 (fr) Analyse et authentification genetiques
WO2004013727A3 (fr) Systemes et procedes informatiques utilisant des locus quantitatifs cliniques et d'expression afin d'associer des genes a des traits
WO2000024937A3 (fr) Techniques paralleles pour analyse genomique
DE69806003D1 (de) Dna polymerasen, die verbesserte fähigkeiten zum einbau markierter nukleotide besitzen
AU2001255518A1 (en) Compositions and methods for array-based nucleic acid hybridization
ATE316152T1 (de) Komplexitätsmanagement und analyse genomischer dna
WO2001090419A3 (fr) Methodes d'analyse genetique d'adn servant a detecter des variances de sequence
WO2005044836A3 (fr) Composes nucleotidiques macromoleculaires et leurs procedes d'utilisation
WO2005035545A3 (fr) Analyse de polymorphisme nucleotidique (snp) de sequences cibles hautement polymorphes
PT2217719E (pt) Oligonucleótidos e suas utilizações
WO2006089238A3 (fr) Dosages multiplex pour inferer l'ascendance
AU2001285219A1 (en) Methods and compositions for identifying nucleic acid molecules using nucleolytic activities and hybridization
WO2006088623A3 (fr) Amplification de sondes de selection
WO2002066684A3 (fr) Medecine personnalisee fondee sur le genome
WO2008076856A3 (fr) Réactifs et procédés permettant de détecter des polymorphismes de cyp2d6
WO2006010150A3 (fr) Gènes domestiques et méthodes d'identification desdits gènes
WO2003083051A3 (fr) Amplification en chaine par transcriptase-polymerase inverse normalise multiplex pour l'evaluation de l'expression genique dans de petits echantillons biologiques
WO2000022171A3 (fr) Systemes et procedes de sequençage par hybridation
WO2002040126A3 (fr) Procedes d'identification de nucleotides dans des positions definies dans des acides nucleiques cibles au moyen de la polarisation de fluorescence
WO2001029262A3 (fr) Reactifs de genotypage, kits et procedes d'utilisation desdits reactifs
WO2003002721A3 (fr) Compositions et methodes de deduction d'une reponse a une statine
EP0787806A3 (fr) Polymorphisme ABO en la séquence glycosyltransférase
WO2006081353A3 (fr) Hybridation comparative et rapide du genome
DE60040231D1 (de) Biallelische Marker die im zusammenhang stehen mit Medikamentenmetabolismus beteiligten Genen
WO2000065095A3 (fr) Methodes et compositions de realisation de dosages d'hybridation reposant sur des jeux ordonnes d'echantillons

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2496155

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2005502072

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2003265572

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2003788685

Country of ref document: EP

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWP Wipo information: published in national office

Ref document number: 2003788685

Country of ref document: EP